Advertisement
Demo

Roche's lung cancer combo treatment wins FDA approval

Dec 07, 2018 , Reuters
Swiss drugmaker Roche Holding AG said on Thursday that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food and Drug Administration as a first-line treatment for a form of lung cancer.


Read the full story...


Trending healthcare news keywords at this moment

medicine state court kids women abortion launches mental care child measles fda death hospital heart disease rise life higher opioid diet risk cancer drug doctors patients study tip work finds sleep report digital news rates